Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hmmm... interesting.
Right into my ear, and others.
Wow... that post of mine you responded to dates back to 2014. :)
Well, if MHRA is trying to stick by the 150 day + 60 (=210) clock off time line, October 3 is 210 days following the March 7th second validation, which I've heard is the one NWBO believes counted as the validation date, not Jan 27, despite the letter Sparky received.
That said, I'm just waiting (trying to be patient) here like so many other longs. Fall starts in a few days, so hopefully, the MHRA MAA answer will come sometime during the Autumn equinox. :)
Well at least we know then that the price won’t drop past $0.304 until the MMs decide to go through you. :)
Agreed... I've been unable to get to the bottom of the reasoning of why anyone would post negative (let alone positive) 24/7/365 on this board and not be invested in some way. It boggles the mind.
But I sense that you’ve spent far longer on this board than you intended. Has the time gotten away from you? Has the story gotten only stronger for you, too?
And we’re closer to approval today than we were “over two years ago.”
No, for ten years, this has been a great opportunity to buy.
You can only delete posts that are less than 48 hours old. So as usual, you are incorrect. :)
That likely means feeding him information beforehand, or his hedge fund buddies... and that's illegal.
Glad to see you're back in with us again. Hopefully this time, you're in for awhile and are able to make some good profits for a charity (presuming that's still your goal?).
:)
Thanks, yes, all good points. :)
I do think that an MHRA MAA approval will help with an FDA MA; which is one important reason I suspect they are waiting to submit.
Interesting… from your link:
You’re right… he does not appear to be the same guy. My mistake. :)
Interesting, seeing as immunotherapies typically work best with melanoma, which is why so many immunotherapy treatments start with melanoma trials, and of course, not GBM.
Excellent! Thanks for delving more into the details as to what this latest MHRA MIA means in the ongoing MAA process. :)
There was a Mike Taylor on the Big Biz show Les often makes an appearance on a couple of weeks ago who indicated on the episode that he’s working with Northwest. We were all speculating who Mike Taylor was and what company he might be with, and someone else had mentioned to me that he might be with Critical Mass. But the picture doesn’t at all match the Mike Taylor who was on the Big Biz show, discussing NWBO.
Here's a link to last year's MIA posting.
https://cms.mhra.gov.uk/mhra/mia/uk-miaimp-54923
Please note, Legal Authorization reads:
I haven’t spoken with him for awhile, but someone else I know has, and he’s fine, just super busy.
You reference the FDA guidance on the use of external controls for clinical trials dated February 2023 and titled: Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products Guidance for Industry (which we should note is still a draft guidance).
https://www.fda.gov/media/164960/download
But when the Statistical Analysis Plan (SAP) for the External Control Arm (ECA) was being designed, this guidance had not been published by FDA. As noted by the company in their 2018 Annual Report (dated April 2, 2019) on page 2:
True… a good start would be to invest in the companies she represents.
I definitely agree... it was mentioned, in connection with a brain tumor. Obviously the writers of the scene weren't as familiar with DCVax as we are, but there is no denying, it was mentioned as the treatment the man in the scene had turned to.
Of course… it’s dialogue from a popular HBO show.
Transcribing the fuller conversation of HBO’s Industry, Season 3, Episode 5, regarding the DCVax conversation:
Sorry... I was responding to Doc Logic re: whether I knew that Direct had initially began as a mouse study... which I obviously did.
It's still a great PR, and IMO, Direct will be amazingly helpful, despite what those who aren't invested but post 24/7/365 state often.
You are right! I remember…
$NWBO's DCVax doesn't involve mice but still nice to see it mentioned this evening on @HBO's Industry. pic.twitter.com/xhqwG9jIJT
— autologous assassin 🇺🇸 🇺🇦 🇮🇱 (@flaskworks) September 9, 2024
It’s nice that you recognize DCVax-L does this. :)
And I would add that many people don’t see the benefit of chemo for unmethylated GBM… so perhaps those patients might have a better chance at increasing their lifespan using DCVax-L (and poly ICLC), and no chemo.
If you follow the thread, you’d read that the problem isn’t with Schwab allowing you to buy NWBO, but rather, they currently won’t let you transfer the shares in from another brokerage. They won’t let you transfer into Schwab any penny stock.
Schwab would unequivocally not let me transfer NWBO shares in from ComputerShare (after telling me they would, at least three times). So I finally had them transferred to a Fidelity account from ComputerShare, who readily accepted them.
Nope… neither are a good look, so probably best for those who keep pointing it out to drop it.
Part of the problem is that 1) many of the brokerages won't accept a transfer of OTC stocks. They'll let you buy OTC shares in their brokerage, but they won't let you transfer them in (having purchased them elsewhere)... Charles Schwab being one of them. Then the second problem is, many of those living in Europe can't open a brokerage account in the U.S. without a U.S. address and a tax ID number.
This problem will be fixed when Northwest gets off the OTC and onto one of the larger ones. But it's currently not a great place to find oneself, unable to buy and only to sell, perhaps on the cusp of a nice swing back up.